Nascent Biotech Company Description

Nascent Biotech, Inc., a clinical-stage biopharmaceutical company, develops monoclonal antibodies for the treatment of various forms of cancer.

It is developing Pritumumab, a drug to treat patients with brain cancer malignancies, such as glioblastoma and malignant astrocytoma, as well as epithelial cancers, including lung, breast, colon, brain, and pancreas cancer.

The company is developing MultiPharm, a proprietary technology platform for cancer therapy, as well as diabetes, autoimmunity, and transplantation.

In addition, it develops CLNH5. Nascent Biotech, Inc. is based in North Palm Beach, Florida.

Nascent Biotech, Inc.

Country	United States
Industry	Biotechnology
Sector	Healthcare
CEO	Sean Carrick

Contact Details

Address: 631 US Hwy 1 North Palm Beach, Nevada 33408 United States
Phone	612 961 5656
Website	nascentbiotech.com

Stock Details

Ticker Symbol	NBIO
Exchange	OTCMKTS
Fiscal Year	April - March
Reporting Currency	USD
ISIN Number	US63108Q1013
SIC Code	2836

Key Executives

Name	Position
Sean Carrick	President, Chief Executive Officer, Secretary and Director
Lowell Holden	Chief Financial Officer, Chief Accounting Officer and Director
Dr. Mark C. Glassy Ph.D.	Founder
Dr. Navpaul Singh M.D.	Chief Medical Consultant